Exhibit 32.1
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Fred Aslan, M.D., Chief Executive Officer of Artiva Biotherapeutics, Inc. (the “Company”), and Neha Krishnamohan, Chief Financial Officer of the Company, each hereby certifies that, to the best of his or her knowledge:
Dated: November 12, 2024
IN WITNESS WHEREOF, the undersigned have set their hands hereto as of the 12th day of November, 2024.
/s/ Fred Aslan, M.D. |
|
| /s/ Neha Krishnamohan |
Fred Aslan, M.D. |
|
| Neha Krishnamohan |
President and Chief Executive Officer |
|
| Chief Financial Officer and EVP, Corporate |
(Principal Executive Officer) |
|
| Development |
|
|
| (Principal Financial Officer and Principal Accounting Officer) |
“This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Artiva Biotherapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.”
